Gene · 8215
Papers1,958
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,958
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulators of Wnt Signaling Pathway Implied in Dentin Pulp Complex Engineering: A Literature Review. | Int J Mol Sci | 2022 | 36142496 | PubTator, text mining | PubMed |
| Prospects and Challenges of Electrospun Cell and Drug Delivery Vehicles to Correct Urethral Stricture. | Int J Mol Sci | 2022 | 36142432 | PubTator, text mining | PubMed |
| Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma. | Biomedicines | 2022 | 36140250 | PubTator, text mining | PubMed |
| tRNA-derived fragment tRF-1020 ameliorates diabetes-induced retinal microvascular complications. | J Cell Mol Med | 2022 | 36128646 | PubTator, text mining | PubMed |
| Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model. | Oncotarget | 2022 | 36128326 | PubTator, text mining | PubMed |
| Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities. | Transl Oncol | 2022 | 36122506 | PubTator, text mining | PubMed |
| Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. | J Oncol | 2022 | 36106333 | PubTator, text mining | PubMed |
| Pyrvinium doubles against WNT-driven cancer. | J Biol Chem | 2022 | 36096200 | PubTator, text mining | PubMed |
| Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer. | Front Immunol | 2022 | 36090993 | PubTator, text mining | PubMed |
| Human Umbilical Cord Mesenchymal Stem Cell-Derived Conditioned Medium Promotes Human Endometrial Cell Proliferation through Wnt/β-Catenin Signaling. | Biomed Res Int | 2022 | 36082157 | PubTator, text mining | PubMed |
| Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach. | Plants (Basel) | 2022 | 36079579 | PubTator, text mining | PubMed |
| The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway. | J Exp Clin Cancer Res | 2022 | 36056393 | PubTator, text mining | PubMed |
| Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report. | Medicine (Baltimore) | 2022 | 36042639 | PubTator, text mining | PubMed |
| Nucleation of the destruction complex on the centrosome accelerates degradation of β-catenin and regulates Wnt signal transmission. | Proc Natl Acad Sci U S A | 2022 | 36037369 | PubTator, text mining | PubMed |
| Hsa_circ_0087302, a circular RNA, affects the progression of osteosarcoma via the Wnt/β-catenin signaling pathway. | Int J Med Sci | 2022 | 36035366 | PubTator, text mining | PubMed |
| Regulation of Embryonic Stem Cell Self-Renewal. | Life (Basel) | 2022 | 36013330 | PubTator, text mining | PubMed |
| PI(4,5)P2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-catenin signaling. | Sci Signal | 2022 | 35998232 | PubTator, text mining | PubMed |
| The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review. | J Dev Biol | 2022 | 35997395 | PubTator, text mining | PubMed |
| Relationship between chronic hypoxia and seizure susceptibility. | CNS Neurosci Ther | 2022 | 35983626 | PubTator, text mining | PubMed |
| Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials. | Int J Biol Sci | 2022 | 35982902 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8215/papers?page=17